MarketPeel
MH

Michael J. Harrington

ELAN
DIRECTOR · ELANCO ANIMAL HEALTH INC · CIK 0001566340
FILING MIX · LIFETIME95%/5%
BUYS
18
SELLS
1
TOTAL VALUE
$506.8K
COMPANIES
3
ACTIVE SINCE
Oct 2019
HOLDINGS NOW
209,951
AVG SELL PX
TRADE KIND
SHOWING 19 / 19
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Michael J. Harrington, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+66.67%+7.75%-1.84%+9.59%+1.14%
14d6+50.00%-1.81%-2.80%+0.99%+1.17%
30d6+33.33%+7.47%+1.37%+6.09%-3.72%
60d6+33.33%-4.78%+1.48%-6.26%-13.73%
90d6+50.00%-1.85%+4.37%-6.22%-5.91%
180d6+16.67%-10.96%+6.18%-17.15%-16.34%
1y6+33.33%-23.37%+12.55%-35.92%-37.52%
2y6(1 pending)+60.00%+0.74%+28.01%-27.27%-49.48%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ELAN · 131,451 shares · as of Aug 12, 2026
032,86365,72698,588131,451202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 18 buys / 1 sellsCOVERAGE · 28 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASE
5,000$21.82$109.1K131,451Aug 12, 2026Aug 13, 2026View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASEGRANT
Stock grant
4,678114,255May 21, 2026May 26, 2026View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASEGRANT
Stock grant
12,196126,451May 21, 2026May 26, 2026View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASEGRANT
Stock grant
10,314109,577Nov 28, 2025Dec 2, 2025View →
NOTV
INOTIV, INC.
PURCHASEGRANT
Stock grant
39,39276,892Mar 14, 2025Mar 18, 2025View →
NOTV
INOTIV, INC.
PURCHASE
10,000$3.98$39.8K37,500Dec 6, 2024Dec 10, 2024View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASEGRANT
Stock grant
18,16999,263Nov 29, 2024Dec 3, 2024View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASE
3,500$14.85$52.0K81,094Aug 22, 2024Aug 26, 2024View →
NOTV
INOTIV, INC.
PURCHASEGRANT
Stock grant
27,50027,500Aug 10, 2024Aug 14, 2024View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASE
3,100$16.29$50.5K77,594Mar 8, 2024Mar 12, 2024View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASEGRANT
Stock grant
20,37474,494Nov 30, 2023Dec 4, 2023View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASEGRANT
Stock grant
18,64954,120Nov 30, 2022Dec 2, 2022View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASEGRANT
Stock grant
7,30735,471Nov 30, 2021Dec 2, 2021View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASE
2,500$29.25$73.1K28,164Nov 30, 2021Dec 2, 2021View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASE
3,000$28.99$87.0K25,684Aug 11, 2021Aug 13, 2021View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASEGRANT
Stock grant
5,88522,684Nov 30, 2020Dec 2, 2020View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASE
4,000$23.84$95.4K16,799Mar 9, 2020Mar 11, 2020View →
LLY
ELI LILLY & CO
PURCHASEGRANT
Stock grant
1,6081,608Jan 2, 2020Jan 6, 2020View →
LLY
ELI LILLY & CO
SALEGRANT
Gift
3,00059,500Oct 24, 2019Jan 6, 2020View →
Other insiders · ELAN
Loading peer insiders…
About this filer
CIK 0001566340
ROLE
Director
PRIMARY
ELAN
COMPANIES
3
ACTIVE SINCE
Oct 2019
MARKETPEEL · /INSIDER/0001566340DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback